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MembraneHCV NS4B, a highly hydrophobic protein involved in the alteration of the intracellular host membranes
forming the replication complex, plays a critical role in the HCV life cycle. NS4B is a multifunctional mem-
brane protein that possesses different regions where diverse and signiﬁcant functions are located. One of
these important regions is the AH2 segment, which besides being highly conserved has been shown to
play a signiﬁcant role in NS4B functioning. We have carried out an in-depth biophysical study aimed at the
elucidation of the capacity of this region to interact, modulate and disrupt membranes, as well as to study
the structural and dynamic features relevant for that disruption. We show that a peptide derived from this
region, NS4BAH2, is capable of speciﬁcally binding phosphatidyl inositol phosphates with high afﬁnity, and
its interfacial properties suggest that this segment could behave similarly to a pre-transmembrane domain
partitioning into and interacting with the membrane depending on the membrane composition and/or
other proteins. Moreover, NS4BAH2 is capable of rupturing membranes even at very low peptide-to-lipid ra-
tios and its membrane-activity is modulated by lipid composition. NS4BAH2 is located in a shallow position in
the membrane but it is able to affect the lipid environment from the membrane surface down to the hydro-
phobic core. The NS4B region where peptide NS4BAH2 resides might have an essential role in the membrane
replication and/or assembly of the viral particle through the modulation of the membrane structure and
hence the replication complex.
© 2013 Elsevier B.V. All rights reserved.ro)phosphate; 18BMP, bis
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Hepatitis C virus (HCV) is an enveloped positive single-stranded
RNA virus, included in the genus Hepacivirus of the Flaviviridae
family. HCV is the major cause of liver diseases, including steatosis,
ﬁbrosis, cirrhosis and hepatocellular carcinoma, and is the leading
indication for liver transplantation [1]. With approximately 170 to
200 million people infected worldwide and no protective vaccine
available at present HCV has emerged as a serious global health
problem, since an estimated 2%–3% of the world population is
afﬂicted by this illness [2,3]. HCV entry into the host cell is
achieved by the fusion of viral and cellular membranes, the replica-
tion of its genome occurs in a membrane-associated replication
complex, and morphogenesis has been suggested to take place in
endoplasmic reticulum (ER) modiﬁed membranes [4]. HCV has a
single-stranded genome, which encodes a polyprotein cleaved by
a combination of cellular and viral proteases to produce the mature
structural and non-structural (NS) proteins [5,6]. There are unique
ties between the HCV life cycle, lipid metabolism, lipid rafts and
speciﬁc lipid environments; more speciﬁcally, the non-structural
protein NS4B is engaged in one way or another with all of them
[6,7].
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least characterized HCV protein and is a highly hydrophobic membrane
protein associated with membranes of an ER-derived modiﬁed com-
partment [8]. The expression of NS4B induces the formation of signiﬁ-
cant intracellular membrane changes, the so called membranous web
[9], which has been postulated to be the HCV RNA replication complex.
NS4B is likely an integral membrane protein with several transmem-
brane domains [10]. NS4B is a multifunctional protein that contains an
ATP/GTPase function [11], displays anti-apoptotic activity [12], is
palmitoylated in the C-terminal region and its N-terminal domain has
a potent polymerization activity [13]. The C-terminal part of NS4B con-
tains two α-helical elements, H1 and H2 which are essential for NS4B
self-interaction and the formation of functional HCV replication com-
plexes [14]. Signiﬁcantly, these segments are able of interacting with
membranes [15,16]. The N-terminal part of NS4B contains a structurally
resolved amphipathic α-helix, AH2, which has been shown to play an
important role in HCV RNA replication, has the potential to traverse
the phospholipid bilayer as a transmembrane segment and is supposed-
ly engaged in protein oligomerization [13,17]. Mutations that affect the
oligomerization of NS4B disrupted membranous web formation and
HCV RNA replication, implying that oligomerization of NS4B is required
for the creation of a functional replication complex. NS4B might be the
protein responsible for binding to speciﬁc lipid domains, such as lipid
rafts, and thereby enabling the recruitment or anchoring of other viral
proteins in order to form the replication complex [18].
We have recently identiﬁed themembrane-active regions of a num-
ber of viral proteins by observing the effect of peptide libraries onmodel
membrane integrity, including HCV NS4B [19–23]. These results
allowed us to propose the location of different segments in these pro-
teins that should be implicated in protein–lipid and protein–protein in-
teractions. One of those membranotropic segments was located where
the AH2 region resides. Considering that the interaction between the
highly hydrophobic HCV NS4B protein and membranes is fundamental
in the viral RNA replication process, it is natural to think of HCV protein/
membrane interaction as an attractive target for antiviral drug develop-
ment. In this work we report the binding and interaction of a peptide
corresponding to the AH2 segment of HCV NS4B protein (peptide
NS4BAH2) with different membrane model systems. We show that
NS4BAH2 is a membrane interacting domain, which strongly partitions
into and interacts with phospholipid biomembranes, modulates the
phospholipid phase behavior and changes its secondary structure
upon binding to the membrane, behaving similarly to other described
viral pre-transmembrane segments. Furthermore, the NS4BAH2 peptide
binds speciﬁcally to different phosphatidyl inositol phosphates
supporting the fact that the NS4B protein might be engaged in a
multifunctional way with membrane trafﬁcking. These data will help
us to understand the molecular mechanism of viral replication which
may lead to new vaccine strategies.
2. Materials and methods
2.1. Materials and reagents
Peptides NS4BAH2 with sequence KLEVFWAKHMWNFISGIQYLA (res-
idues 45 to 65, HCV strain 1a_H77 NS4B numbering), NS4BAH2-His with
sequence KLEVFWAKHMWNFISGIQYLAGHHHHHHG and NS4BSCAH2-His
with sequence VNFQFMAISGHEWKLYLAKIWGHHHHHHG, were syn-
thesized with N-terminal acetylation and C-terminal amidation on
an automatic multiple synthesizer (Genemed Synthesis, San
Antonio, TX, USA). The peptides were puriﬁed by reverse-phase
high-performance liquid chromatography (Vydac C-8 column,
250 × 4.6 mm, ﬂow rate 1 ml/min, solvent A, 0.1% triﬂuoroacetic
acid, solvent B, 99.9 acetonitrile and 0.1% triﬂuoroacetic acid) to
>95% purity, and its composition and molecular mass were con-
ﬁrmed by amino acid analysis and mass spectroscopy. Since
triﬂuoroacetate has a strong infrared absorbance at approximately1673 cm−1, which interferes with the characterization of the pep-
tide Amide I′ band [24], residual triﬂuoroacetic acid, used both in
peptide synthesis and in the high-performance liquid chromatogra-
phy mobile phase, was removed by three lyophilization/solubilization
cycles in 10 mM HCl [25]. Peptides were solubilized in water/TFE at
50% (v/v). Bovine brain phosphatidylserine (BPS), bovine liver L-α-
phosphatidylinositol (BPI), brain L-α-phosphatidylinositol-4-phosphate
(PI4P), cholesterol (Chol), egg L-α-phosphatidylglycerol (EPG),
egg L-α-phosphatidic acid (EPA), egg L-α-phosphatidylcholine
(EPC), egg sphingomyelin (ESM), egg transphosphatidylated L-α-
hosphatidylethanolamine (TPE), tetramyristoyl cardiolipin (CL),
1,2-dimyristoylphosphatidylserine (DMPS), 1,2-dimyristoylphos-
phatidylcholine (DMPC), 1,2-dimyristoylphosphatidylglycerol (DMPG),
1,2-dimyristoylphosphatidic acid (DMPA), 1,2-dipalmitoyl-sn-glycero-
3-phosphocholine (DPPC), 1,2-distearoyl-sn-glycero-3-phosphocholine
(DSPC), 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1-palmitoyl-
2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1,2-dielaidoyl-sn-
glycero-3-phosphatidylethanolamine (DEPE), N-palmitoyl-D-erythro-
sphingosylphosphorylcholine (PSM), bis(monomyristoylglycero)
phosphate (14BMP), bis(monooleoylglycero)phosphate (18BMP)
and liver lipid extract were obtained from Avanti Polar Lipids (Alabas-
ter, AL, USA). The synthetic ER membrane contained EPC/CL/BPI/TPE/
BPS/EPA/SM/Chol at a molar ratio of 59:0.37:7.4:18:3.1:1.2:3.4:7.8
[45], the synthetic late endosome membrane (LEM) contained EPC/
TPE/BPI/18BMP at a molar ratio of 5:1:1:2 [46], whereas the synthetic
ER58:6 contained EPC/CL/BPI/TPE/BPS/EPA/ESM/Chol at a molar ratio
of 58:6:6:6:6:6:6:6. 5-Carboxyﬂuorescein (CF, >95% by HPLC),
5-doxyl-stearic acid (5-NS), 16-doxyl-stearic acid (16-NS), deuterium
oxide (99.9%), Triton X-100, EDTA and HEPES were purchased from
Sigma-Aldrich (Madrid, ES). 1,6-Diphenyl-1,3,5-hexatriene (DPH),
and 1-(4-trimethylammoniumphenyl)-6-phenyl-1,3,5-hexatriene
(TMA-DPH) were obtained from Molecular Probes (Eugene, OR).
All other chemicals were commercial samples of the highest purity
available (Sigma-Aldrich, Madrid, ES). Water was deionized, twice-
distilled and passed through a Milli-Q equipment (Millipore Ibérica,
Madrid, ES) to a resistivity higher than 18 MΩ cm.
2.2. Vesicle preparation
Aliquots containing the appropriate amount of lipid in chloroform/
methanol (2:1 vol/vol) were placed in a test tube, the solvents
were removed by evaporation under a stream of O2-free N2, and ﬁ-
nally, traces of solvents were eliminated under vacuum in the dark
for >3 h. The lipid ﬁlms were resuspended in an appropriate buffer
and incubated either at 25 °C or 10 °C above the phase transition
temperature (Tm) with intermittent vortexing for 30 min to hydrate
the samples and obtain multilamellar vesicles (MLV). The samples
were frozen and thawed ﬁve times to ensure complete homogeniza-
tion and maximization of peptide/lipid contacts with occasional
vortexing. Large unilamellar vesicles (LUV) with a mean diameter
of either 0.1 μmor 0.2 μm(CF and FD leakagemeasurements, respec-
tively) were prepared from MLV by the extrusion method [26] using
polycarbonate ﬁlters (Nuclepore Corp., Cambridge, CA, USA) as de-
scribed previously [15]. Small unilamellar vesicles (SUV) were pre-
pared from MLVs as described previously [16]. The phospholipid
and peptide concentrations were measured by methods described
previously [27,28].
2.3. Acrylamide quenching of Trp emission, quenching with lipophilic
depth probes and steady-state ﬂuorescence anisotropy
Aliquots from a 4 M solution of the water-soluble quencher were
added to the solution-containing peptide in the presence and absence
of liposomes at a peptide/lipid molar ratio of 1:100. The results
obtained were corrected for dilution and the scatter contribution
was derived from acrylamide titration of a vesicle blank. The data
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Quenching with TMA-DPH and DPH depth probes was made as previ-
ously described [30]. Quenching studies with lipophilic probes were
performed by successive addition of small amounts of 5-NS or
16-NS in ethanol to peptide samples incubated with LUV. The ﬁnal
concentration of ethanol was kept below 2.5% (v/v) to avoid any sig-
niﬁcant bilayer alterations. After each addition an incubation period
of 15 min was kept before the measurement. The Stern–Volmer
quenching constant, KSV, is a measure of the accessibility of Trp to
the quencher molecule [30].
2.4. Membrane leakage and peptide binding to vesicles
CF and FD membrane leakage was made as previously described
[31]. Leakage was quantiﬁed on a percentage basis as previously de-
scribed [30,32]. Peptide binding to lipid membranes was studied
using steady-state ﬂuorescence spectra recorded in a SLM Aminco
8000C spectroﬂuorometer with excitation and emission wavelengths
at 290 and 342 nm, respectively, and 4 nm spectral bandwidths. The
data were analyzed and partition coefﬁcients, KP (i.e. the amount of
peptide bound to the bilayer as a fraction of the total peptide present
in the system), were obtained as described previously [16].
2.5. Differential scanning calorimetry
MLVs were formed as stated above in 20 mM HEPES, 100 mM
NaCl, 0.1 mM EDTA, pH 7.4. The peptide was added to obtain a pep-
tide/lipid molar ratio of 1:15. The ﬁnal volume was 0.8 ml (0.6 mM
lipid concentration), and incubated 10 °C above the Tm of each phos-
pholipid for 1 h with occasional vortexing. Differential scanning calo-
rimetry (DSC) experiments were performed in a VP-DSC differential
scanning calorimeter (MicroCal LLC, MA) as described in [15].
2.6. Magic angle spinning (MAS) 31P NMR
Samples were prepared as described above and concentrated by
centrifugation (14,000 rpm for 15 min). MAS 31P NMR spectra were
acquired on a Bruker 500 MHz Avance spectrometer (Bruker BioSpin,
Rheinstetten, Germany) using a Bruker 4-mm broad band MAS probe
under both static and MAS conditions (see [15] for further details).
Under static conditions, the samples showed a broad asymmetrical
signal with a low-frequency peak and a high-frequency shoulder
characteristic of bilayer structures (data not shown).
2.7. Infrared spectroscopy
Approximately 25 μl of a pelleted sample in D2O [15] was placed
between two CaF2 windows separated by 56-μm thick Teﬂon spacers
in a liquid demountable cell (Harrick, Ossining, NY). The spectra were
obtained and analyzed as previously described [16,33].
2.8. Lipid overlay assay
Two different nitrocellulose membrane strips, i.e., PIP Array strip
(cat. No. P-6100), and Membrane Lipid strip (cat. No. P-6002) from
Echelon Biosciences Inc., UT, USA, were used. The bound His-derived
peptides were detected on the strips using the protocol stated by
the manufacturer. In brief, the strips were blocked using PBS plus
1% non-fat dry milk for 1 h at room temperature, incubated with
the peptides overnight at 4 °C, washed six times for 10 min in wash-
ing buffer containing PBS plus 0.1% Tween-20 and detected by chemi-
luminescence using a Penta-His antibody (Qiagen, Germany),
anti-mouse IgG-HRP (Sigma, Spain), and ECL Detection reagent
(Amersham, GE Healthcare, Spain). The concentration of the peptides
in the solution was 20 μg/ml.2.9. Atomic force microscopy (AFM)
A 1 mM SUV suspension (10 mM HEPES buffer pH 7.4 in NaCl
150 mM) was deposited in the presence of CaCl2 4 mM on a freshly
cleavedmica substrate, as described elsewhere [34,35]. The lipid sam-
ple was incubated for 30 min at room temperature. Afterwards, the
sample was rinsed at least 10 times with buffer and set to equilibrate
for another 30 min at room temperature. Samples were scanned in
contact mode on a NanoWizard II equipment (JPK Instruments, Berlin,
Germany) mounted on top of an Axiovert 200 inverted optical micro-
scope (Carl Zeiss, Jena, Germany). Measurements were performed
using uncoated silicon nitride cantilevers OMCL-TR800PSA-1 from
Olympus (Tokyo, Japan) with a typical stiffness of 0.15 N/m. All images,
for the peptide concentrations and lipid compositions evaluated, were
obtained with the same or close AFM parameter (set-point, scan rate,
gain) values. Controls where buffer was added instead of peptide solu-
tionwere performedwith the same incubation times andmeasurement
conditions. The scan rate was 2 Hz and the force applied on the sample
was maintained at the lowest possible value by continuously adjusting
the set-point and gain during the imaging. Images were acquiredwith a
typical 512 × 512 resolution. Data were analyzed using JPK image pro-
cessing software Version 3 (JPK Instruments) and Gwyddion Version
2.19 (Czech Metrology Institute).
3. Results
NS4B, due to its highly hydrophobic character, is the least character-
ized of the HCV proteins and therefore many questions remain unan-
swered about its structure and function. NS4B is predicted to
comprise an N-terminal part, a central part comprising several trans-
membrane domains and a C-terminal part [8,10,36]. Further, HCV
NS4B possesses three amphipathic α-helical segments, one at the
N-terminal part of the protein (segment AH2) [17] and two at the
C-terminal part (segments H1 andH2) [37].We have recently identiﬁed
severalmembrane-active regions ofNS4B, one of thempertaining to the
segment where the AH2 segment resides [33]. This segment presents a
high water-to-interface transfer free energy region immediately
followed by a region of high water-to-bilayer transfer free energy albeit
with some overlapping between them (Fig. 1) [10]. As observed in
Fig. 1, this region is quite conserved among the different genotypes of
HCV; the conservation of this pattern across so many different strains
of HCV indicates that this sequence is likely to be an important region
in the NS4B protein. The free energy pattern displayed in Fig. 1 is char-
acteristically distinctive of the pre-transmembrane domains (also called
stem or membrane-proximal domains) of several viral fusion proteins,
characterized by their strong propensity to partition into and interact
withmembrane interfaces [13,17,23,38–43]. These domains are usually
rich in aromatic amino acids and play essential roles in membrane de-
stabilization. Interestingly, it has been reported that this segment
plays an important role in HCV RNA replication, interacts with ER de-
rived membranes, has the ability to interact with the phospholipid bi-
layer and most likely has the capability to transverse the membrane
given the right conditions [13,17]. In this work we report the binding
and interaction of a peptide corresponding to the AH2 segment of pro-
tein NS4B fromHCV strain 1a_H77 (peptide NS4BAH2, Fig. 1) in aqueous
solution and in the presence of different membranemodel systems.We
have characterized the structural changes taking place in the peptide
and in the membrane and have deﬁned it as a membrane interacting
domain with remarkable properties.
The ability of the NS4BAH2 peptide to interact with membranes
was determined from ﬂuorescence studies of the peptide's intrinsic
Trp residues [44] using model membranes containing diverse phos-
pholipid compositions (Fig. 1B). The peptide was bound to the mem-
brane surface with high afﬁnity since partition constant values (Kp) in
the range 105 were obtained for the different phospholipid composi-
tions studied (Table 1). Interestingly, the larger values were found for
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Fig. 1. (A) Average normalized water-to-bilayer (───) and water-to-interface (−∙−∙−) transfer free energies in kcal/mol for the NS4BAH2 peptide (NS4B residues 45 to 65) (see
Ref. [10]). Transfer free energies values have been inverted to match the direction of transfer from water-to-bilayer and water-to-interface (the more negative the value, the higher
the transfer free energy) [69]. The sequence of the NS4BAH2 peptide (HCV strain 1a_H77) and the ClustalW2 alignment corresponding to thirty-one reference HCV strains (se-
quences 1A_1, 1A_H77, 1B_CON1, 1B_HC-J4, 1C_HC-G9, 1G_1804, 2A_HC-J6, 2B_JPUT971017, 2C_BEBE1, 2I_D54, 2K_VAT96, 3A_NZL1, 3B_TR-KJ, 3K_JK049, 4A_ED43, 4D_24,
4F_CM_DAV9905, 4K_PB65185, 5A_EUH1480, 6A_6A33, 6B_TH580, 6C_TH846, 6D_VN235, 6E_D42, 6F_C-0044, 6G_JK046, 6H_VN004, 6K_VN405, 6O_D85, 6T_D49 and 7A_QC69
were obtained from the HCVdb database, http://www.hcvdb.org/index.asp) are also shown. The similarity of the residues in the alignment is shown below it (identical residues
are denoted by *, conserved residues by :, and semi-conserved residues by ·). (B) Change in the ﬂuorescence intensity of the Trp residue of the NS4BAH2 peptide in the presence
of increasing lipid concentration, (C) Stern–Volmer plots for the quenching of the ﬂuorescence of the Trp residue of the NS4BAH2 peptide in the presence of acrylamide and (D) Stern–
Volmer plots for the depth-dependent quenching of the ﬂuorescence of the Trp residue of the NS4BAH2 peptide in the presence of 5-NS (ﬁlled symbols) and (■), EPC/EPA at a molar
ratio of 5:2 (▼), EPC/Chol at a molar ratio of 5:1(♦), EPC/BPS at a molar ratio of 5:2 (○), EPC/ESM/Chol at a molar ratio of 5:1:1 (●), EPC/ESM/Chol at a molar ratio of 5:3:1 (□), EPC/
BPS/Chol at a molar ratio of 5:2:1 (◊), EPC/EPA/Chol at a molar ratio of 5:2:1 (Δ), liver membranes (▲), synthetic ER membranes (►) and synthetic ER586 membranes (◄). Pure peptide
in buffer is represented by (×) inpanel (C). In (D), the lipid compositions usedwere EPC (■,□), EPC/ESM/Chol at amolar ratio of 5:1:1 (●,○), EPC/BPS at amolar ratio of 5:2 (♦,◊), EPC/EPA
at a molar ratio of 5:2 (▼,∇), liver membranes (▲,Δ) and synthetic ERmembranes (◄,◁).Vertical bars indicate standard deviations of themean of triplicate samples. The lipid to peptide
ratio was 100:1 for experiments using acrylamide and both 5- and 16-NS probes.
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plex mixture and EPC/BPS at a molar ratio of 5:2, as well as ESM
and Chol containing compositions. Stern–Volmer plots for the
quenching of Trp by the water-soluble quencher acrylamide [45],
recorded in the absence and presence of lipid vesicles, are shown in
Fig. 1C and the resultant Stern–Volmer constants are presented in
Table 1. The Trp residues were totally accessible to acrylamide since
linear Stern–Volmer plots were obtained and in all cases, the
quenching of the peptide Trp residues showed an acrylamide depen-
dent concentration behavior. In aqueous solution, the Trp residues
were highly exposed to the solvent that led to a more efﬁcient
quenching. However, in the presence of the phospholipid mem-
branes, the extent of quenching was signiﬁcantly reduced, indicating
a poor accessibility of the Trp residues to the aqueous phase, consis-
tent with its incorporation into the lipid bilayer. The extent ofquenching was much lower in the presence of negatively charged
membranes than in membranes containing other phospholipid com-
positions, in accordance with the results shown above. The transverse
location of the NS4BAH2 peptide when incorporated in the ﬂuid phase
of membranes having different phospholipid compositions was eval-
uated by monitoring the relative quenching of the ﬂuorescence of the
Trp residues by the lipophilic spin probes 5-NS and 16-NS (Fig. 1D).
The KSV values for both probes are presented in Table 1. For liposomes
composed of EPC, EPC/ESM/Chol at a molar ratio of 5:1:1, the ER com-
plex mixture and EPC/EPA at a molar ratio of 5:2, the differences be-
tween the two probes were not very high; however, for membranes
composed of the liver extract and the EPC/BPS at a molar ratio of
5:2 differences were signiﬁcant (Table 1). Combining all these data,
we could conclude that the Trp residues are localized in the mem-
brane in between these two probes.
Table 1
Partition coefﬁcients (Kp) and Stern–Volmer quenching constants (KSV) obtained from the ﬂuorescence of the Trp residues of the NS4BAH2 peptide in buffer and in the presence of
different model membranes.
LUV composition KP (×10−5 M−1) KSV (M−1) KSV (M−1) KSV (M−1)
Trp Acrylamide 5-NS 16-NS
EPC 0.22 ± 0.07 6.36 ± 0.10 19.74 ± 1.29 16.64 ± 2.03
EPC/Chol 5:1 0.48 ± 0.31 4.83 ± 0.31 – –
EPC/BPS 5:2 21.6 ± 0.57 3.70 ± 0.19 20.03 ± 2.23 5.88 ± 1.90
EPC/EPA 5:2 0.38 ± 0.05 5.36 ± 0.32 26.57 ± 2.10 28.55 ± 3.22
EPC/ESM/Chol 5:1:1 13.9 ± 3.60 5.69 ± 0.13 18.76 ± 1.68 21.30 ± 2.23
EPC/ESM/Chol 5:3:1 1.98 ± 0.20 6.04 ± 0.10 – –
ER complex mixture 1.03 ± 0.21 5.42 ± 0.13 1.45 ± 0.59 1.03 ± 0.46
LIVER 1.72 ± 0.30 3.68 ± 0.14 20.87 ± 1.22 11.39 ± 2.91
EPC/BPS/Chol 5:2:1 0.12 ± 0.03 – – –
EPC/EPA/Chol 5:2:1 0.20 ± 0.04 – – –
ER58:6 complex mixture 2.68 ± 0.68 3.57 ± 0.11 – –
Buffer – 12.47 ± 0.21 – –
1942 M.F. Palomares-Jerez et al. / Biochimica et Biophysica Acta 1828 (2013) 1938–1952The effect of the NS4BAH2 peptide on the release of encapsulated
ﬂuorophores trapped inside model membranes was studied to ex-
plore the interaction of the peptide with phospholipid membranes
[16]. NS4BAH2 was able to induce the release of encapsulated CF in a
dose-dependent manner and the effect was signiﬁcantly different
for different lipid compositions (Fig. 2A). The NS4BAH2 peptide in-
duced a signiﬁcant percentage of leakage for liposomes composed of
EPC/18BMP at a molar ratio of 5:2, even at a (very high) lipid/peptide
ratio of 800:1 the observed leakage was virtually 100% (Fig. 2A). Lipo-
somes composed of EPC or EPC/Chol at a molar ratio of 5:1 elicited
signiﬁcant leakage effects, inducing leakage values of about 85–80%0
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standard deviations of the mean of triplicate samples.at a lipid/peptide ratio of 800:1. Liposomes composed of negatively
charged phospholipids presented lower leakage values. At the lipid/
peptide ratio of 800:1, liposomes composed of the LEM and ER com-
plex mixtures, as well as EPC/EPA and EPC/BPS at a molar ratio of
5:2 presented leakage values of 35–25% (Fig. 2A). Chol addition to
the LEM composition slightly lowered the observed leakage values
(Fig. 2A). Similarly, Chol addition to the EPC/EPA and EPC/BPS compo-
sitions lowered leakage signiﬁcantly, since at lipid/peptide ratio of
200:1 leakage values of 5–10% were observed. Interestingly, liver ex-
tract liposomes were the ones that elicited the lowest leakage values,
even at high peptide/lipid ratios (Fig. 2A). Fig. 2B shows the extent of0
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and Chol. The highest leakage values were found for lipid composi-
tions containing the highest ESM proportions: leakage values of 93%
and 89% were observed for lipid compositions of EPC/ESM at molar
ratios of 5:4 and 5:3 at a lipid/peptide ratio of 800:1. The inclusion
of Chol reduced the leakage, since leakage values of 87% and 81%
were found for lipid compositions of EPC/ESM/Chol at molar ratios
of 5:3:1 and 5:1:1, respectively. When the Chol content was higher
than ESM, leakage was much reduced (EPC/ESM/Chol at a molar ratio
of 5:1:3 presented 37% of leakage). The inclusion of Chol but no ESM
on EPC membranes reduced leakage, since EPC/Chol at molar ratios of
5:1 and 5:3 presented leakage values of 72% and 11%, respectively. De-
ﬁnitively Chol lowers the leakage elicited by the peptide, since its addi-
tion to different membrane compositions induced signiﬁcant lower
leakage values. We have studied the effect of the NS4BAH2 peptide on
membrane rupture using a complex lipid composition resembling the
ER membrane to assess the effect of each component of the complex
mixture (Fig. 2C). The synthetic ER complex membrane used above
was composed of EPC, CL, BPI, TPE, BPS, EPA, ESM and Chol at a molar
ratio of 59:0.37:7.4:18:3.1:1.2:3.4:7.8 [46]. Therefore we have designed
an additional ER synthetic membrane composed of the same types of
lipids, i.e., EPC/CL/BPI/TPE/BPS/EPA/ESM/Chol, but at a molar ratio of
58:6:6:6.6:6:6:6 (ER58:6). As shown in Fig. 2C, NS4BAH2 was capable
of rupturing the ER58:6 complex membrane: at a lipid/peptide ratio
of 150:1 about 40% leakage was observed. In contrast, a leakage
value of about 60% was obtained for the ER complex mixture at a
lipid/peptide ratio of 150:1 (Fig. 2A). Leakage values were minor at
higher lipid/peptide ratios. For example, at a lipid/peptide ratio of
800:1 no leakage was observed for the ER58:6 complex membrane,
but it was about 30% for the ER complex one. Removing either Chol
or CL leakage values increased, whereas removing either ESM, BPS
or TPE leakage values decreased (Fig. 2C). The removal of either
EPA or BPI did not have any signiﬁcant difference.
Since CF is a relatively small molecule (Stokes radius about 6 Å) we
have studied the release of membrane-encapsulated bigger size mole-
cules such as FITC–dextrans FD20 and FD70 (Stokes radius about 33 Å
and 60 Å, respectively) [47,48]. In that way we could characterize the
size of the poreswhichwould be formed, if any, by theNS4BAH2 peptide.
As observed in Fig. 2D and E, NS4BAH2 was capable of inducing a signif-
icant percentage of leakage for both FD20 and FD70 ﬂuorophores, al-
though at slightly slower different values than CF at comparable lipid/
peptide ratios. For example, 80% CF leakage was observed for the ER
complex mixture but 70% and 90% for FD20 and FD70 respectively.
Lower values were observed for negatively-charged phospholipid
containing compositions. For EPC/EPA and EPC/BPS at a molar ratio of
5:2 about 40% and 50% leakage values were observed for FD20 and
FD70 but 80% for CF (Fig. 2A, D and E). Smaller values were observed
for Chol containing liposomes. For CF, 80–90% leakage was observed
(Fig. 2B) but 10–20% for FD20 (Fig. 2D) and about 30–60% for FD70
(Fig. 2E). The capacity of the NS4BAH2 peptide to induce leakage of
FITC–dextrans although to a lower extent than the small CF molecule
demonstrates that NS4BAH2 is capable of forming pores in the mem-
brane [49], although rupture of the membrane at a later stage should
not be ruled out.
The effect of the peptide on the structural and thermotropic prop-
erties of phospholipid membranes was investigated by measuring the
steady-state ﬂuorescence anisotropy of the ﬂuorescent probes DPH
and TMA-DPH incorporated into model membranes composed of dif-
ferent types of phospholipids as a function of temperature (Fig. 3).
When DMPC was studied in the presence of the NS4BAH2 peptide,
there was a small change in the cooperativity of the thermal transi-
tion, as well as a small decrease in the Tm of DMPC when compared
with the pure phospholipid (Fig. 3A and B). Additionally, the anisot-
ropy of both DPH and TMA-DPH probes was slightly decreased and
increased below and above the Tm, respectively. When the negatively
charged phospholipids DMPG, DMPA, and DMPS were studied,NS4BAH2 induced a decrease in the Tm of the main transition; this de-
crease was more noticeable for DMPG and DMPS than for DMPA
(Fig. 3C, D, E, F, G and H). Similar to DMPC, the anisotropy of both
DPH and TMA-DPH was slightly affected both below and above Tm.
The effect of NS4BAH2 on two phospholipids, namely PSM and
14BMP, was also studied (Fig. 3I, J, K and L). Similar to what was
found above, the peptide decreased slightly the Tm and increased
the anisotropy of DPH above but not below Tm. Three different binary
mixtures were also studied, i.e., DMPC/DMPS at a molar ratio of 1:1
(Fig. 4M and N), DMPC/DMPA at a molar ratio of 1:1 (Fig. 3O and
P), and DMPC/PSM at a molar ratio of 1:1 (Fig. 3Q and R). In all of
the mixtures, NS4BAH2 induced a decrease in the Tm of the main tran-
sition, being more noticeable in both DMPC/DMPS and DMPC/DMPA
samples than in the DMPC/PSM one. Similar to what was found
above, the anisotropy of both DPH and TMA-DPH above but not
below the Tm was increased. NS4BAH2 is therefore capable of affecting
the thermal transition Tm of these phospholipids as observed by both
types of probes; the peptide changed the anisotropy of DPH to a
greater extent than TMA-DPH, so it should be located slightly deeper
in the membrane, inﬂuencing the ﬂuidity of the phospholipids [50].
The effect of the NS4BAH2 peptide on the thermotropic phase behav-
ior of phospholipid multilamellar vesicles was also studied using differ-
ential scanning calorimetry, DSC (Fig. 4). DMPC and DMPG display two
endothermic peaks on heating, the pre-transition (appearing at about
12–14 °C, Lβ′–Pβ′) and the main transition (appearing at about 23–
24 °C, Pβ′–Lα). Incorporation of NS4BAH2 in DMPC at a lipid/peptide
ratio of 15:1 (Fig. 4A), did not signiﬁcantly alter the thermotropic be-
havior of the phospholipid, since the peptide did not completely abolish
the pre-transition; themain transition of DMPCwas slightly broadened
and shifted to lower temperatures than the Tm. When NS4BAH2 was in-
corporated into DMPG at the same lipid/peptide ratio, the pre-
transition waned, and the main transition broadened signiﬁcantly giv-
ing rise to two different peaks, which should be due to mixed phases
(Fig. 4B). DMPS and DMPA present a single highly cooperative phase
transition that corresponds to the chain melting transition from the
gel to the liquid-crystalline phases [51]. The presence of NS4BAH2 at a
lipid/peptide molar ratio of 15:1 induced a slight decrease of
cooperativity in DMPS as well as a shift to lower temperatures of the
main phase transition of the phospholipid (Fig. 4C). In the case of
DMPA, NS4BCter induced a slight shift to higher temperatures of the
main phase transition peak of the phospholipid but no decrease in
cooperativity was observed (Fig. 4D). DEPE presents two transitions, a
gel to liquid-crystalline phase transition (Lβ–Lα) in the lamellar phase
at about 38 °C and in addition a lamellar liquid-crystalline to
hexagonal-HII (Lα–HII) phase transition at about 63 °C [52]. NS4BAH2
did not induce any effect on the main transition of the lipid but de-
creased the cooperativity of the lamellar to hexagonal phase transition
(Fig. 4E). As observed in Fig. 4F, 14BMP displays two endothermic
peaks on heating, a small transition at about 19 °C from a quasi-
crystalline phase Lc1 to a quasi-crystalline phase with different tilt
angle Lc2 and a main transition at about 41 °C from a quasi-crystalline
phase Lc2 to the liquid phase Lα [53]. The incorporation of NS4BAH2
into 14BMP membranes at a lipid/peptide ratio of 15:1 did not alter
the thermotropic behavior of the phospholipid, since no signiﬁcant ef-
fect was observed on the two transitions of 14BMP (Fig. 4F). PSM pre-
sents a single highly cooperative phase transition at about 41 °C
corresponding to the gel-to-liquid-crystalline phase main transition.
The incorporation of NS4BAH2 into PSMmembranes altered the thermo-
tropic behavior of the phospholipid, inducing a broadening of the main
transition peak (Fig. 4E).
Since the 31P NMR isotropic chemical shifts of both ESM and EPC
head-group peaks are resolvable under MAS conditions we have
used 31P MAS NMR to observe EPC, ESM and Chol containing mixtures
in the presence of the NS4BAH2 peptide. When the mixtures EPC/ESM
at a molar ratio of 5:3 and EPC/ESM/Chol at a molar ratio of 5:3:3
were studied, they presented two bands corresponding to EPC and
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The chemical shift of both EPC and ESM resonances was not signiﬁ-
cantly different neither in the absence nor in the presence of
NS4BAH2, but the line widths of the 31P resonances of EPC and ESMDMPS
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mixture and in the absence of the peptide was 48 and 51 Hz, respec-
tively; however, the width of the EPC and ESM peaks was 79 and
86 Hz, respectively, when NS4BAH2 was present. The presence of the
NS4BAH2 peptide induced a similar increase in the width of both EPC
and ESM peaks in the complex mixtures, indicating no speciﬁc inter-
action for both types of phospholipids. However, it is interesting to
note that the increase in bandwidth induced by the peptide is smaller
for the EPC/ESM/Chol sample than for the EPC/ESM one. The increase
in bandwidth for EPC and ESM in the EPC/ESM sample was 38 Hz
whereas the increase in bandwidth for EPC and ESM in the EPC/
ESM/Chol sample was 31 and 35 Hz, respectively. These data would
be in accordance with the ﬂuorescence and leakage data shown
above, since Chol reduces the interaction of the peptide with the
membrane.
We have analyzed the infrared Amide I′ band of the NS4BAH2 pep-
tide located between 1700 and 1600 cm−1 in the presence of differ-
ent membrane model systems (Fig. 6). For the peptide in solution,
the broad Amide I′ band was asymmetric and displayed bands at dif-
ferent frequencies with different intensities (Fig. 6E). At low temper-
atures, a relatively narrow band at about 1621 cm−1 was apparent
with a shoulder at about 1645 cm−1 and a small peak at about
1681 cm−1. At higher temperatures, the band at 1621 cm−1 shifted
to about 1623 cm−1, the band at about 1645 cm−1 disappeared and
a new band at about 1656 cm−1 appeared, albeit with lower intensi-
ty. The small peak at about 1681 cm−1 did not change in frequency
(Fig. 6E). The appearance of a band at approximately 1618–
1622 cm−1 concomitantly with another one at about 1680 cm−1
would indicate the existence of aggregated β structures, whereas
the broad band with the intensity maxima at about 1645 cm−1
would correspond to a mixture of unordered and helical structures,
and the band at about 1645 cm−1 would mainly correspond to helicalstructures [54,55]. The NS4BAH2 peptide would then change from a
mixture of helical, unordered and aggregated β structures at low tem-
peratures to a mixture of helical and aggregated β structures at high
temperatures, this transitional change in overall structure occurring
steadily from low to high temperatures (Fig. 6E). In the presence of
DMPC the Amide I′ envelope of the NS4BCter peptide presented a
broad band with a maximum at about 1623 cm−1 at all temperatures.
The spectrum envelope would suggest that, although helical and
unordered structures might be present, the main secondary structure
component consists of aggregated structures (Fig. 6F). In the presence
of either DMPG, DMPA or BMP and at all temperatures, the Amide I′
envelope of NS4BAH2 was rather similar. In this case, the broad band
was asymmetric, with a maximum at about 1624 cm−1 and a shoul-
der at about 1655 cm−1 (Fig. 6G, H and I). These data would suggest
that the main secondary structure component should be aggregated
structures although helical structures might be present; the peptide
would present a high degree of conformational stability in the pres-
ence of phospholipids.
We have also analyzed the ester C_O band of the phospholipids
located between 1745 and 1720 cm−1 in the presence of the
NS4BAH2 peptide (Fig. 6). The frequency maximum of the ester C_O
band of DMPC displayed one transition at about 24 °C, coincident
with the main gel to liquid crystalline phase transition of the pure
phospholipid (Fig. 6A and J). In the presence of NS4BAH2, the frequen-
cy of the ester C_O band of DMPC displayed only one transition at
about 24 °C, in accordance with the DSC data (see Fig. 4A). However,
its absolute frequency was higher in the presence of the peptide than
in its absence, suggesting that the peptide increased the intensity of
the 1743 cm−1 component relative to the 1727 cm−1 one, i.e., the
amount of non-hydrogen bonded C_O ester bands increased in the
presence of the peptide [56,57]. The pattern of the thermotropic
phase behavior exhibited by pure DMPG is similar to that of pure
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1947M.F. Palomares-Jerez et al. / Biochimica et Biophysica Acta 1828 (2013) 1938–1952DMPC (Fig. 6B and K). However, in the presence of the peptide and at
low temperatures, the C_O carbonyl band of DMPC presented a main
peak and a shoulder, which could suggest the formation of a
quasi-crystalline lamellar phase [58,59]. At higher temperatures the
two peaks coalesced into a broad C_O band similar in appearance
to the one observed for pure DMPG, suggesting the formation of a
normal liquid crystalline phase (Fig. 6B and K). The ester C_O band
of DMPA displayed a single transition in accordance with the DSC
data (Fig. 6C and L). In the presence of NS4BAH2 only one transitionwas observed but the frequency of the C_O band at low tempera-
tures appeared at about 1738 cm−1 indicating, as above, that the
amount of free, i.e., non-hydrogen, bonded C_O ester bands in-
creased in the presence of the peptide. At temperatures above the
main transition the frequencies in the absence and in the presence
of the peptide were similar (Fig. 6L). The ester C_O band of pure
14BMP displayed a sharp band at low temperatures and a broad one
at high temperatures, deﬁning the transition temperature of the
phospholipid (Fig. 6D and M). In the presence of NS4BAH2, the ester
1948 M.F. Palomares-Jerez et al. / Biochimica et Biophysica Acta 1828 (2013) 1938–1952C_O band of 14BMP displayed a transition at about 30 °C and anoth-
er one at about 45 °C. In this last case, the C_O band was formed by
two sharp peaks and a shoulder.
In order to investigate the possible lipid binding speciﬁcity of
the NS4BAH2 peptide a peptide–lipid overlay assay was performed
using different nitrocellulose membrane strips with different lipids
and concentrations (Fig. 7). As stated in the Materials and methods sec-
tion, a penta-His derived peptide from NS4BAH2 was used, NS4BAH2-His,
in addition to a scrambled version, NS4BSCAH2-His. As shown in Fig. 7A,
NS4BAH2-His was capable of binding with high afﬁnity to different phos-
phatidyl inositol phosphates, namely phosphatidylinositol-4-phosphate,
phosphatidylinositol-4,5-bisphosphate and phosphatidylinositol-3,4,5-
trisphosphate; however, the binding of the scrambled derivative
was not as remarkable. Array strips with increasing amount of
phosphatidylinositol phosphates per spot were also used, showing
that NS4BAH2-His was capable of binding strongly to several
phosphatidylinositol-phosphates, mainly phosphatidylinositol-4-
phosphate and phosphatidylinositol-5-phosphate (Fig. 7B). NS4BAH2-His
was also capable of binding weakly to other phosphatidyl inositol phos-
phates but only at the highest lipid concentrations used in the assay
(Fig. 7B). The lipids on the nitrocellulose membrane strips do not imitate
the real biological membrane structure but give a qualitative answer
to binding of the peptide to certain phospholipids. Nonetheless, the
NS4BAH2-His peptide was able of binding to several phosphatidyl ino-
sitol phosphates in a speciﬁc way but no other lipids.
Given the capability of the NS4BAH2 peptide to disrupt and absorb
into membranes, we were interested in visualizing the effect of the
peptide on the topography and stability of phase separated zwitter-
ionic planar lipid bilayers. AFM was used for this purpose. In this)tops/lomp(
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(PI(4,5)P2), phosphatidylinositol-3,4,5-trisphosphate (PI(3,4,5)P3), cholesterol (Chol), sphingo
each one of the lipids. (B) Concentration array of phosphatidylinositol (PI), phospha
phosphatidylinositol-3,4,5-trisphosphate (PI(3,4,5)P3). The strips shown in the ﬁgure are fromwork, lipid bilayers composed of POPC/DPPC at a molar ratio of 1:1,
POPC/PSM at a molar ratio of 5:3, DOPC/PSM/Chol at a molar ratio
of 5:3:2 and DOPC/DSPC/Chol at a molar ratio of 2:2:1 were imaged
before and after incubation with NS4BAH2 at 0.5 μM, 1 μM and 3 μM
(Fig. 8). The peptide induced signiﬁcant changes on POPC/DPPC and
POPC/PSM membrane topography but did not cause any signiﬁcant
changes on DOPC/DSPC/Chol membranes (Fig. 8). In the case of
DOPC/PSM/Chol membrane systems, upon addition of peptide at a
concentration of 1 μM and after 30 min incubation, slight defects
and small aggregates over the membrane surface were observed.
Upon addition of peptide at 3 μM to membrane systems with Chol,
too many aggregates were observed (image not shown). Upon addi-
tion of the peptide at a concentration of 1 μM to POPC/DPPC and
POPC/PSM membrane systems, small perturbations of the gel matrix
borders were observed. In addition, the peptide at 3 μM causes signif-
icant changes in the gel and ﬂuid matrix for POPC/DPPC and for POPC/
PSM, being the effect more pronounced at the gel matrix borders.
4. Discussion
Most, if not all, of the HCV non-structural proteins including NS4B,
play a central role in viral particle formation and budding, but their
speciﬁc function in replication and/or assembly remains poorly un-
derstood [6,60]. HCV NS4B is a highly hydrophobic protein that has
been suggested to alter intracellular host membranes making possi-
ble the formation of the HCV replication complex, playing a critical
role in the HCV life cycle. NS4B is a multifunctional membrane protein
that possesses different regions where diverse and signiﬁcant func-
tions are located. One of these important regions is the AH2 segment,PI P(
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Fig. 8. Effect of NS4BAH2 on the topography of zwitterionic supported lipid bilayers. AFM height images of POPC/DPPC (1:1) and POPC/PSM (5:3) supported lipid bilayers, and AFM
error images of DOPC/DSPC/Chol (2:2:1) and DOPC/PSM/Chol (5:3:2) bilayers are shown in the presence of NS4BAH2 peptide at 0.5 μM, 1 μM and 3 μM. Control measurements were
performed in the absence of peptide.
1949M.F. Palomares-Jerez et al. / Biochimica et Biophysica Acta 1828 (2013) 1938–1952which besides being highly conserved has been shown to play a sig-
niﬁcant role in NS4B functioning [13,17]. Since the biological role/
roles of NS4B is/are intrinsically related to the membrane, we have
extended our previous works to investigate the binding and interac-
tion of this highly conserved membranotropic AH2 region of NS4B,i.e., peptide NS4BAH2, with different membrane model systems. We
have carried out an in-depth biophysical study aimed at the elucida-
tion of the capacity of this region to interact and disrupt membranes,
as well as to study the structural and dynamic features which might
be relevant for that disruption. Our ﬁndings give interesting clues to
1950 M.F. Palomares-Jerez et al. / Biochimica et Biophysica Acta 1828 (2013) 1938–1952a key region in the NS4B protein that might be implicated in the HCV
life cycle.
We have shown that the NS4BAH2 peptide binds with high afﬁnity
to phospholipid model membranes, as it has been found for other
peptides [44,61]. Hydrophilic quenching probes further demonstrat-
ed binding of the peptide to the membrane, since the NS4BAH2 pep-
tide was less accessible for quenching by acrylamide implying a
buried location. The lipophilic probe quenching results suggest a
shallow-to-intermediate location of the peptide in the membrane. In-
terestingly, these data suggest that the insertion of the peptide into
the bilayer palisade depends on phospholipid composition. We have
also shown that the NS4BAH2 peptide is capable of affecting the steady
state ﬂuorescence anisotropy of ﬂuorescent probes located into the
palisade structure of the membrane, since the peptide was able of de-
creasing the mobility and cooperativity of the phospholipid acyl
chains when compared to the pure phospholipids. Calorimetry exper-
iments indicated that the NS4BAH2 peptide induced the presence of
mixed lipid phases, enriched and impoverished in peptide. These re-
sults suggest that the location of the peptide is at or near the mem-
brane interface, inﬂuencing the ﬂuidity of the phospholipids, most
probably with an in-plane orientation rather than in a transmem-
brane position [62]. This location would be in accordance with previ-
ous data obtained for the two proposed α-helical elements of the
C-terminal region [16,33]. Interestingly, NS4BAH2 is capable of binding
different phosphatidyl inositol phosphates with high afﬁnity, imply-
ing that this NS4B segment could be implicated in either the recruit-
ment of phosphatidyl inositol phosphates in the replication complex
or speciﬁc domain formation or both [63]. Moreover, its interfacial
properties suggest that this segment could behave similarly to a
pre-transmembrane domain partitioning into and interacting with
the membrane depending on the membrane composition and/or
other proteins [36,64,65], being the responsible of the ﬂuctuation of
the protein between different topologies and therefore possible loca-
tions [8,9,66].
The NS4BAH2 peptide was also capable of altering membrane sta-
bility causing the release of ﬂuorescent probes through pores in the
membrane. The release of these probes was dependent on both the
lipid/peptide molar ratio and lipid composition. The formation of
pores would imply a possible oligomerization of the peptide, which
would substantiate the possible role of this NS4B segment in
protein-protein oligomerization [13]. Apart from that, the binding of
AH2 to speciﬁc phospholipids in the membrane as demonstrated in
this work could also promote protein oligomerization through the
formation of lipid domains in the membrane. The highest CF release
was observed for liposomes containing the phospholipid BMP,AH2
TM TM TM
53-71
72-90
91-111
113-13
NB
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Fig. 9. Schematic representation of protein NS4B from HCV. The N-terminal region of the pro
α-helical segments, H1 and H2. In between these two regions, ﬁve transmembrane (TM) se
phospholipids such as PIPs. NS4B contains a nucleotide binding domain (NBD) as well as a pa
different segments [10]. The protein segments have been roughly drawn to scale.although signiﬁcant leakage values were also observed for liposomes
composed of both zwitterionic and negatively-charged phospho-
lipids. Signiﬁcantly, at a lipid to peptide molar ratio as high as 800
to 1, a leakage value of 100% was observed for BMPmembranes. Inter-
estingly, Chol seems to lower the leakage elicited by the peptide,
since its addition to different membrane compositions induced
lower leakage values. The differential effect observed when Chol
was included in the membrane was also supported by the AFM
data. These differences could be a consequence of inﬂuence of choles-
terol in the membrane penetration of peptides preventing its inser-
tion as it has been observed for other peptides [67]. As a general
trend, it can be observed that the higher the ESM content and the
lower the Chol content, the higher the leakage values are. These re-
sults were corroborated by using a speciﬁc ER complex membrane,
indicating that the speciﬁc disrupting effect elicited by the NS4BAH2
peptide should depend on the phospholipid head-group characteris-
tics, i.e., charge and possibly hydrogen bonding, although hydropho-
bic interactions within the bilayer should not be ruled out. The 31P
MAS NMR results show that both phospholipids, EPC and ESM, exhib-
it a lower degree of mobility in the presence of the peptide [68]. Tak-
ing into account all these data, the speciﬁc disrupting effect elicited
by NS4BAH2 should be primarily due to hydrophobic interactions
within the bilayer, although the speciﬁc charge of the phospholipid
head-groups affects, slightly, the extent of membrane leakage.
The infrared spectra of the Amide I′ region of the fully hydrated
NS4BAH2 peptide in solution at low temperatures displayed a coexis-
tence of unordered, aggregated and helical structures, which at high
temperatures became a mixture of helical and aggregated structures.
In the presence of different phospholipids as well as at different tem-
peratures, the main secondary structure component was mainly ag-
gregated structure. These results imply that the secondary structure
of the NS4BAH2 peptide was affected by its binding to the membrane,
so that membrane binding modulates the secondary structure of the
peptide as it has been suggested for other peptides [31,33]. In the
presence of membranes, the overall secondary structure of the pep-
tide did not change, demonstrating a high stable conformation in
the bound state. At the same time, differences in the frequency and
number of bands corresponding to the carbonyl band of the phospho-
lipids were observed, showing that peptide binding also modulated
phospholipid conformation.
The NS4B region where peptide NS4BAH2 resides might have an
essential role in the membrane replication and/or assembly of the
viral particle through the modulation of the membrane structure
and hence the replication complex. The conservation of its structure
as well as its physical and chemical properties should be essential inH1 H2
TM TM
204-211
234-2443
135-156
170-189
D
1 residues)
tein contains the amphipathic segment AH2, whereas the C-terminal part contains two
gments can be found. As shown in this work, AH2 would be capable of binding speciﬁc
lmitoylation site, as indicated. Residue numbers show the approximate extension of the
1951M.F. Palomares-Jerez et al. / Biochimica et Biophysica Acta 1828 (2013) 1938–1952its function. Our results add new information about how this region
can contribute to the interaction with the membrane. Although the
peptide is not deeply buried in the membrane, its interaction with
the membrane depends on its composition and it is able to affect
the lipid milieu from the membrane surface down to the hydrophobic
core. The existence of a number of hydrophobic and interfacial
regions in HCV NS4B protein would suggest that they could oscillate
between metastable and stable conformations; moreover, their dif-
ferent biological functions would deﬁne the mechanism of the viral
replication complex formation. We have shown previously that
NS4B possesses ﬁve transmembrane segments [10] ﬂanked by the
N- and C-terminal regions where segments AH2 and H1/H2 are locat-
ed [13,15,16,33] (Fig. 9). Whereas the integral part of the protein,
showing ATP/GTPase activity, localizes it in the membrane, the N- and
C-terminal regions modulate membrane structure, bind speciﬁc phos-
pholipids and are responsible of homo and/or hetero-oligomerization.
NS4B, a multifunctional integral membrane protein with several seg-
ments having deﬁned biological functions, essential for the formation
of the replication complex, would therefore have a dynamic membrane
topology which would be inherent to its biological functioning. These
conformational changes could be envisaged as driven by the interaction
with speciﬁc lipids or domains in themembrane or even proteins. Con-
sequently, the results described in this work identify an important re-
gion in the HCV NS4B protein, which might be of critical importance
in the HCV life cycle. Additionally, pharmacological disruption of NS4B
interaction with membranes could represent the basis for a novel ap-
proach to anti-HCV therapy.Acknowledgements
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